Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AAPL

Apple

$154.72

1.42 (0.93%)

, BAYRY

Bayer

$0.00

(0.00%)

10:13
01/23/19
01/23
10:13
01/23/19
10:13
Hot Stocks
Greenlight sold Apple, Mylan, Perrigo in 2018, Einhorn states in investor letter »

In Greenlight's…

AAPL

Apple

$154.72

1.42 (0.93%)

BAYRY

Bayer

$0.00

(0.00%)

MYL

Mylan

$28.82

-0.08 (-0.28%)

PRGO

Perrigo

$45.48

0.67 (1.50%)

CLB

Core Laboratories

$68.36

0.49 (0.72%)

AER

AerCap

$45.99

0.77 (1.70%)

BHF

Brighthouse Financial

$35.77

0.18 (0.51%)

GM

General Motors

$38.25

0.07 (0.18%)

TSLA

Tesla

$291.84

-6.96 (-2.33%)

AGO

Assured Guaranty

$40.03

0.375 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 30

    Jan

  • 31

    Jan

  • 06

    Feb

  • 10

    Feb

  • 12

    Feb

  • 14

    Feb

MYOK

MyoKardia

$44.28

-1.2 (-2.64%)

, CCXI

ChemoCentryx

$11.71

-0.74 (-5.94%)

08:35
01/23/19
01/23
08:35
01/23/19
08:35
Hot Stocks
MyoKardia appoints William Fairey CCO »

MyoKardia (MYOK)…

MYOK

MyoKardia

$44.28

-1.2 (-2.64%)

CCXI

ChemoCentryx

$11.71

-0.74 (-5.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$51.26

-2.09 (-3.92%)

08:19
01/23/19
01/23
08:19
01/23/19
08:19
Recommendations
Ultragenyx analyst commentary at SunTrust »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$80.66

-2.42 (-2.91%)

08:09
01/23/19
01/23
08:09
01/23/19
08:09
Hot Stocks
CAMP4 Therapeutics, Alnylam announce rare disease research collaboration »

CAMP4 Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

, AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

05:43
01/23/19
01/23
05:43
01/23/19
05:43
Hot Stocks
Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial »

Biohaven Pharmaceutical…

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

ALNY

Alnylam

$80.66

-2.42 (-2.91%)

05:27
01/23/19
01/23
05:27
01/23/19
05:27
Initiation
Alnylam initiated at UBS »

Alnylam initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
BAYRY

Bayer

$0.00

(0.00%)

19:08
01/22/19
01/22
19:08
01/22/19
19:08
Periodicals
Bayer requests that CA judge limit evidence in Roundup trial, Reuters says »

Bayer's Monsanto has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RARE

Ultragenyx

$51.07

-2.28 (-4.27%)

10:35
01/22/19
01/22
10:35
01/22/19
10:35
Recommendations
Ultragenyx analyst commentary at Piper Jaffray »

Piper remains buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUPH

Aurinia Pharmaceuticals

$6.91

-0.63 (-8.36%)

, AGN

Allergan

$156.73

-3.55 (-2.21%)

10:31
01/22/19
01/22
10:31
01/22/19
10:31
On The Fly
Aurinia drops after Phase 2 trial results fail to meet primary endpoint »

Shares of Aurinia…

AUPH

Aurinia Pharmaceuticals

$6.91

-0.63 (-8.36%)

AGN

Allergan

$156.73

-3.55 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

  • 18

    May

  • 28

    May

ALXN

Alexion

$113.31

-3.66 (-3.13%)

, AMGN

Amgen

$201.74

-2.18 (-1.07%)

10:24
01/22/19
01/22
10:24
01/22/19
10:24
On The Fly
Alexion slips on Soliris EU patent setback, though analysts see limited impact »

Shares of Alexion…

ALXN

Alexion

$113.31

-3.66 (-3.13%)

AMGN

Amgen

$201.74

-2.18 (-1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 04

    Feb

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.